Botox Vial Economics Calculator

Botox vial cost: what providers pay in 2026

A 100-unit vial of Botox (onabotulinumtoxinA) costs providers between $400 and $600 wholesale, depending on your distributor, volume tier, and whether you're buying through a GPO. The manufacturer list price (WAC) from Allergan is $656 for a 100-unit vial, but authorized distributors discount based on volume commitments. The 50-unit vial is priced proportionally at roughly half, so it buys waste control on light days, not a lower cost per unit.

Your cost per unit is not the vial price divided by 100. It's the vial price divided by the units you inject into paying patients. If you're losing 8 to 12 units per vial to syringe dead space, reconstitution residual, and end-of-day remnants, your per-unit cost is 8-12% higher than the number on the invoice.

Dysport and Xeomin have different unit equivalencies and pricing. This calculator works for any neurotoxin. Enter your vial cost and unit count.

How to calculate Botox cost per unit and profit margin

Profit margin on Botox is straightforward once you know your cost per usable unit. Take your vial cost, divide by usable units (after waste), and compare to what you charge. If you're paying $4.89 per usable unit and charging $15, your gross margin is 67%.

Healthy gross margins on neurotoxins sit between 60% and 70%. Below 55%, your injectable program may not cover overhead once you factor in provider time, supplies, and room cost. Above 75%, check whether your pricing is competitive for your market. You might be leaving volume on the table.

The calculator above factors in waste automatically. Enter your expected waste percentage and it shows your margin after waste, not the theoretical one.

Two types of Botox waste and how to cut each one

Waste splits into two categories with different fixes. Mechanical waste is predictable and largely solvable with equipment. Operational waste is a scheduling and workflow problem.

Mechanical waste: syringe dead space

Every time you draw from the vial and inject, a small amount of product stays trapped in the syringe hub, the gap between the needle base and the barrel. With standard syringes, that's roughly 0.04–0.08 mL per draw. At a typical dilution of 2.5 mL per 100-unit vial (4 units per 0.1 mL), each draw loses about 2 units to dead space. Over a full vial, that adds up to 4–5 units that never reach the patient.

This is largely fixable. Low dead space (LDS) syringes (TSK STERiJECT, BD Low Dead Space) redesign the hub to nearly eliminate the gap, cutting mechanical loss to roughly 0.5 units per vial. The syringes cost $0.50–$1.00 each versus pennies for standard ones, but at $5+ per unit of Botox, the math is straightforward. A practice using 20 vials per month recovers roughly $400–$500 per month in product that would otherwise stay in the syringe.

Operational waste: scheduling and workflow

The bigger and more variable source of waste is operational: patient no-shows after reconstitution, partial vials left over at end of day, and reconstituted product that expires before the next tox patient. Unlike dead space, this varies widely by practice. Solo injectors with unpredictable schedules can see 7–10% operational waste, while high-volume practices that batch tox appointments can push it below 3%.

The biggest levers: schedule tox patients back-to-back so each vial is used in a single session, reconstitute only what you'll use that day, and track reconstitution timestamps to avoid discarding viable product. Allergan recommends use within 24 hours of reconstitution. Some practices extend to 1–2 weeks based on published stability data. The risk past 24 hours is not safety but potency degradation that leads to patient complaints.

At 20 vials per month with 8% total waste (roughly half mechanical, half operational) and a $480 vial cost, you're losing $768 per month, over $9,200 per year. LDS syringes and tighter scheduling can cut that in half.

When to reorder and how to track lot expiry

Unopened Botox vials are stable for 36 months refrigerated. Once reconstituted, the clock starts. Allergan's label says 24 hours; see the waste section above for how practices handle extended use.

Track lot numbers, expiration dates, and reconstitution timestamps for every vial. This documentation is your defense if a patient reports an adverse event and your liability shield if a batch gets recalled.

Reorder when you have two weeks of inventory left based on your average weekly vial consumption. Overstocking ties up cash and increases expiry risk. Understocking means turning away tox patients or emergency-ordering at worse pricing.

Frequently asked questions